Companies › Danaher · Global Markets & Policy
Danaher Corporation
- NYSE: DHR
US maker of life sciences tools, diagnostics and biotechnology manufacturing products.
Next earnings report: Oct 21, 2026. Danaher quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $12.7M, purchases $0. All Danaher insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Rainer Blair President & CEO, Director | Open-market sale indirect | 11,307 | $217.77 | $2.5M | Form 4 ↗ |
| Aug 21, 2026 | Rainer Blair President & CEO, Director | Open-market sale indirect | 39,193 | $218.73 | $8.6M | Form 4 ↗ |
| Aug 21, 2026 | Rainer Blair President & CEO, Director | Open-market sale indirect | 7,755 | $219.35 | $1.7M | Form 4 ↗ |
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $26.6B | $23.9B | $23.9B | $24.6B |
| Operating income | $7.5B | $5.2B | $4.9B | $4.7B |
| Net income | $7.2B | $4.8B | $3.9B | $3.6B |
| Diluted EPS | $9.66 | $6.38 | $5.29 | $5.05 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-10-13 · 8-K — Director or officer change; Other events
- 2026-08-03 · 8-K — Director or officer change; Regulation FD disclosure; Other events
- 2026-07-21 · 8-K — Results of operations
- 2026-07-21 · 10-Q
- 2026-06-03 · 8-K — New financial obligation; Other events
- 2026-05-07 · 8-K — Director or officer change; Shareholder vote results
- 2026-04-29 · 8-K — Material agreement; Other events
- 2026-04-21 · 8-K — Results of operations
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.